HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Retinal vasculopathy in a family with autosomal dominant dyskeratosis congenita.

AbstractBACKGROUND:
Dyskeratosis congenita is a rare multisystem bone marrow failure genetic disorder characterized by reticular skin hyperpigmentation, nail dystrophy, and oral leukoplakia. Clinical ophthalmic features in these patients include retinal hemorrhages, retinal vasculopathy, telangiectasia, and macular exudates.
METHODS:
Complete family medical history, clinical examination, complete blood profile, ophthalmologic examination, fundus color photography and fundus fluorescein angiography, and optical coherence tomography.
RESULTS:
We report a case of a young white adult male with a family history of clinically diagnosed autosomal dominant dyskeratosis congenita, who presented with retinal edema and peripheral retinal ischemia. The sister had milder manifestations and the father had very subtle manifestations.
CONCLUSIONS:
This case is consistent with the previously reported observations of genetic anticipation and variable expressivity in the retinal findings of dyskeratosis congenita.
AuthorsCharles A Johnson, Mark Hatfield, Jose S Pulido
JournalOphthalmic genetics (Ophthalmic Genet) Vol. 30 Issue 4 Pg. 181-4 (Dec 2009) ISSN: 1744-5094 [Electronic] England
PMID19852575 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Anticipation, Genetic
  • Dyskeratosis Congenita (complications, genetics)
  • Female
  • Fluorescein Angiography
  • Genes, Dominant
  • Humans
  • Ischemia (diagnosis, etiology)
  • Macular Edema (diagnosis, etiology)
  • Male
  • Middle Aged
  • Retinal Hemorrhage (diagnosis, etiology)
  • Retinal Vessels (pathology)
  • Tomography, Optical Coherence
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: